|
|
EY-01Y3454
|
2-(Methacryloyloxy)ethyl 2-(trimethylammonio)ethyl phosphate, 96%
|
67881-98-5
|
1G、5G
|
￥0.0
|
|
|
|
EY-01Y3448
|
N-[3-(Dimethylamino)propyl]methacrylamide, 99%
|
5205-93-6
|
25G、100G、500G
|
￥0.0
|
|
|
|
EY-01Y3428
|
4-Nitroquinoline N-oxide, 98%
|
56-57-5
|
1G、5G、250MG
|
￥0.0
|
|
|
|
EY-01Y3445
|
3'-Azido-3'-deoxythymidine(Zidovudine), 98%
|
30516-87-1
|
1G、5G、250MG
|
￥0.0
|
|
|
|
EY-01Y3439
|
2-(Dimethylamino)ethyl methacrylate, 99%
|
2867-47-2
|
250G、1KG
|
￥0.0
|
|
|
|
EY-01Y3435
|
2-(Dimethylamino)ethyl acrylate, 98%, stabilized with MEHQ
|
2439-35-2
|
25ML、100ML、500ML
|
￥0.0
|
|
|
|
EY-01Y3458
|
2-(2-Ethoxyethoxy)ethyl acrylate, 95%
|
7328-17-8
|
100G
|
￥0.0
|
|
|
|
EY-01Y3437
|
2'-Deoxy-5-fluorouridine, 98%, an oncology drug that belongs to the class known as antimetabolites with an GI50 of 5.1 μM for the inhibition of PEPT1
|
50-91-9
|
100MG、500MG
|
￥0.0
|
|
|
|
EY-01Y3441
|
1-Vinyl-2-pyrrolidinone, 99.5%, stabilized with MEHQ
|
88-12-0
|
100G、500G
|
￥0.0
|
|
|
|
EY-01Y3455
|
1,2-Dipalmitoyl-sn-glycero-3-phosphocholine, 98%
|
63-89-8
|
25MG、100MG
|
￥0.0
|
|
|
|
EY-01Y3436
|
(2-Hydroxypropyl)-β-cyclodextrin
|
128446-35-5
|
25G、100G、500G
|
￥0.0
|
|
